{"id":"W2791308824","doi":"10.1158/1078-0432.ccr-17-3452","title":"Safety and Antitumor Activity of Pembrolizumab in Patients with Estrogen Receptor–Positive/Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":387,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Pembrolizumab; Medicine; Breast cancer; Internal medicine; Oncology; Adverse effect; Cancer; Response Evaluation Criteria in Solid Tumors; Estrogen receptor; Nausea; Gastroenterology; Phases of clinical research; Toxicity; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001356018,0.0003276449,0.0008186615,0.0001941939,0.000185016,0.0004277311,0.000199356,0.0003945352,0.0007952895],"category_scores_gemma":[0.001097769,0.0001789776,0.0004918594,0.0001979878,0.0002386393,0.000400208,0.0001355899,0.0007945142,0.00019024],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004166706,"about_ca_system_score_gemma":0.000381762,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002133958,"about_ca_topic_score_gemma":0.0004650876,"domain_scores_codex":[0.999619,0.0001906868,0.00003497733,0.00006001852,0.00005748852,0.00003784602],"domain_scores_gemma":[0.9994965,0.0001518734,0.0001941897,0.00003177688,0.00004104886,0.00008455034],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.3380796,0.01710979,0.1996755,0.001786192,0.003199091,0.000816722,0.0004558388,0.003494541,0.1146146,0.0002207987,0.003118099,0.3174292],"study_design_scores_gemma":[0.1158284,0.4329844,0.4036038,0.0002274797,0.002898192,0.003437915,0.0002482893,0.006357475,0.02369453,0.0003572458,0.01030828,0.0000540318],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9960961,0.003115147,0.0001498792,0.00008618322,0.00001366585,0.00006697779,0.0001022708,0.000008133437,0.0003616949],"genre_scores_gemma":[0.9987317,0.0005521959,0.0001658149,0.000132644,0.00002882415,0.0000476741,0.0001674696,0.000001934279,0.0001718083],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001356018,"threshold_uncertainty_score":0.007171392,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06109298004932549,"score_gpt":0.4370445413124408,"score_spread":0.3759515612631153,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}